Investment analysts at Lifesci Capital issued their Q1 2025 EPS estimates for Protara Therapeutics in a note issued to ...
18h
Fintel on MSNCantor Fitzgerald Initiates Coverage of Protara Therapeutics (TARA) with Overweight RecommendationFintel reports that on March 14, 2025, Cantor Fitzgerald initiated coverage of Protara Therapeutics (NasdaqGM:TARA) with a ...
Cantor Fitzgerald initiated coverage of Protara Therapeutics (TARA) with an Overweight rating and no price target The firm sees “multi-bagger ...
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...
President Trump sent markets into another tailspin by announcing additional tariffs on Canada, suggesting a falling stock ...
Rolinda Acres presents a remarkable narrative of blending tradition with technology, guided by both heritage and adaptability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results